scispace - formally typeset
Y

Yan Li

Researcher at Fourth Military Medical University

Publications -  187
Citations -  4349

Yan Li is an academic researcher from Fourth Military Medical University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 33, co-authored 148 publications receiving 3127 citations. Previous affiliations of Yan Li include Xi'an Jiaotong University.

Papers
More filters
Journal ArticleDOI

Cell-free therapy based on adipose tissue stem cell-derived exosomes promotes wound healing via the PI3K/Akt signaling pathway.

TL;DR: It is demonstrated that ADSC‐derived exosomes can promote fibroblast proliferation and migration and optimize collagen deposition via the PI3K/Akt signaling pathway to further accelerate wound healing.
Journal ArticleDOI

The promotion of bone regeneration through positive regulation of angiogenic-osteogenic coupling using microRNA-26a.

TL;DR: Host specific real-time PCR test of the neo-formed bone demonstrated that miR-26a optimized bone regeneration mainly due to simultaneously regulating endogenous angiogenesis-osteogenesis coupling, providing evidence that miRNA-based therapy can be a valuable tool to promote bone regeneration.
Journal ArticleDOI

Targeting mitochondrial dynamics by regulating Mfn2 for therapeutic intervention in diabetic cardiomyopathy.

TL;DR: This study provides the first evidence that imbalanced mitochondrial dynamics induced by down-regulated Mfn2 contributes to the development of diabetic cardiomyopathy (DCM).
Journal ArticleDOI

MiRNA-29b suppresses tumor growth through simultaneously inhibiting angiogenesis and tumorigenesis by targeting Akt3.

TL;DR: The role of miR-29b in anti-angiogenesis and anti-tumorigenesis is demonstrated is through targeting Akt3 and inducing VEGF and C-myc arrest in breast cancer cells, indicating that this single miRNA could be used as an efficient anti-cancer therapeutic agent to address a critical challenge in cancer therapy.
Journal ArticleDOI

Resveratrol-induced cell inhibition of growth and apoptosis in MCF7 human breast cancer cells are associated with modulation of phosphorylated Akt and caspase-9.

TL;DR: It is shown that resveratrol affects the growth of human breast cancer cell lines MCF7, MDA-MB-231, SK-BR-3, and Bcap-37 in a dose-dependent manner and thatMCF7 is the most sensitive among the four cell lines.